Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers
Hospital to Home: Cognitively Impaired Elders/Caregivers
Status: Enrolling
Updated:  12/31/1969
Penn Presbyterian Medical Center
416
mi
from 43215
Philadelphia, PA
Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers
Hospital to Home: Cognitively Impaired Elders/Caregivers
Status: Enrolling
Updated: 12/31/1969
Penn Presbyterian Medical Center
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
The BRAIN ICU Study: Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors
Status: Enrolling
Updated:  12/31/1969
Saint Thomas Hospital
338
mi
from 43215
Nashville, TN
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
The BRAIN ICU Study: Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors
Status: Enrolling
Updated: 12/31/1969
Saint Thomas Hospital
338
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
The BRAIN ICU Study: Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
The BRAIN ICU Study: Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
Understanding Caregiver Adaptation to Pervasive Developmental Disorders
Status: Enrolling
Updated:  12/31/1969
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
Understanding Caregiver Adaptation to Pervasive Developmental Disorders
Status: Enrolling
Updated: 12/31/1969
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
643
mi
from 43215
Boston, MA
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Fatty Acid Levels and Memory in Breastfed Children
The Influence of FADS2 rs 174575 on Breastmilk Fatty Acid Levels and the Recognition Memory Abilities of 6-month Old Breastfed Infants and Follow-up
Status: Enrolling
Updated:  12/31/1969
Nutrition Research Institute
334
mi
from 43215
Kannapolis, NC
Fatty Acid Levels and Memory in Breastfed Children
The Influence of FADS2 rs 174575 on Breastmilk Fatty Acid Levels and the Recognition Memory Abilities of 6-month Old Breastfed Infants and Follow-up
Status: Enrolling
Updated: 12/31/1969
Nutrition Research Institute
334
mi
from 43215
Kannapolis, NC
Click here to add this to my saved trials
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
FDDNP-PET Imaging in Persons at Risk for Chronic Traumatic Encephalopathy
Status: Enrolling
Updated:  12/31/1969
UCLA Longevity Center
1972
mi
from 43215
Los Angeles, CA
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
FDDNP-PET Imaging in Persons at Risk for Chronic Traumatic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
UCLA Longevity Center
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients
A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
643
mi
from 43215
Boston, MA
A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients
A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Research Institute
1669
mi
from 43215
Sun City, AZ
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Research Institute
1669
mi
from 43215
Sun City, AZ
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
1958
mi
from 43215
Irvine, CA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
1958
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine - Neuropsychiatric Center
1958
mi
from 43215
Orange, CA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine - Neuropsychiatric Center
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Wien Center for Clinical Research
991
mi
from 43215
Miami Beach, FL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Wien Center for Clinical Research
991
mi
from 43215
Miami Beach, FL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of South Florida Health Byrd Alzheimer Institute
831
mi
from 43215
Tampa, FL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of South Florida Health Byrd Alzheimer Institute
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Kansas
621
mi
from 43215
Fairway, KA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Kansas
621
mi
from 43215
Fairway, KA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Boston University
643
mi
from 43215
Boston, MA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Boston University
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Michigan at Ann Arbor
165
mi
from 43215
Ann Arbor, MI
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Michigan at Ann Arbor
165
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health
1757
mi
from 43215
Las Vegas, NV
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health
1757
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
DENT Neurologic Institute
301
mi
from 43215
Amherst, NY
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
DENT Neurologic Institute
301
mi
from 43215
Amherst, NY
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
312
mi
from 43215
Winston-Salem, NC
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
312
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University
130
mi
from 43215
Beachwood, OH
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University
130
mi
from 43215
Beachwood, OH
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Tulsa Clinical Research
750
mi
from 43215
Tulsa, OK
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Tulsa Clinical Research
750
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Butler Hospital Memory & Aging Program
619
mi
from 43215
Providence, RI
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Butler Hospital Memory & Aging Program
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Roper St. Francis Healthcare
525
mi
from 43215
Charleston, SC
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Roper St. Francis Healthcare
525
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
394
mi
from 43215
Madison, WI
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto HSC / Stanford School of Medicine
2100
mi
from 43215
Palo Alto, CA
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto HSC / Stanford School of Medicine
2100
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Bioclinica Research Orlando
795
mi
from 43215
Orlando, FL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Bioclinica Research Orlando
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Bioclinica Research North
764
mi
from 43215
The Villages, FL
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Bioclinica Research North
764
mi
from 43215
The Villages, FL
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated:  12/31/1969
Howard University
328
mi
from 43215
Washington,
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Howard University
328
mi
from 43215
Washington,
Click here to add this to my saved trials